How a ‘pain-o-meter’ could improve treatments
Elie Dolgin • September 25, 2024
Pain is defined subjectively, but an objective measure of the experience promises to transform its management.
Read at Nature Outlook.
Paul Mischel is championing the importance of odd rings of DNA in tumors — and their promise as targets for cancer therapy.
Edits create cells that don’t trigger an immune response, allowing implant recipient to forego immune-suppressing drugs.